FindTrial
Sign In

Emergency administration of fibrinogen concentrate for hemorrhage: a protocol for systematic review and meta-analysis

Emergency administration of fibrinogen concentrate for hemorrhage: a protocol for systematic review and meta-analysis - Emergency administration of fibrinogen concentrate for hemorrhage: a protocol for systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000041598
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trauma, gastrointesitinal haemorrhage, surgery, postpartum

Interventions

None listed

Sponsors

Sapporo city general hospital Emergency and critical care center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We include the randomized controlled trials that the intervention for severe hemorrhagic diseases by fibrinogen concentrate.

Exclusion criteria

Exclusion criteria: Observational studies Hemorrhage in the elective surgery

Design outcomes

Primary

MeasureTime frame
The primary outcome will be in-hospital—

Secondary

MeasureTime frame
Secondary outcome will be the quantity of the transfusions within 24hours, blood loss within 24hours, thrombotic events (i.e. deep venous thrombosis, pulmonary embolization, myocardial infarction and stroke), multiple organ failure, or acute organ dysfunction (i.e. acute kidney injury etc.) length of intensive care unit stay and length of hospital stay.—

Countries

Japan

Contacts

Public ContactYuki Itagaki

Sapporo city general hospital Emergency and critical care center

koaraninaritaizo@gmail.com011-726-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026